BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
7.15
+1.86 (35.21%)
At close: Jan 23, 2026
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $120.12 million as of January 23, 2026. Its market cap has decreased by -51.91% in one year.
Market Cap
120.12M
Enterprise Value
96.35M
Revenue
292.21M
Ranking
n/a
PE Ratio
8.38
Stock Price
$7.15
Market Cap Chart
Since August 4, 2009, BioStem Technologies's market cap has increased from 4.77M to 120.12M, an increase of 2,416.00%. That is a compound annual growth rate of 21.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 120.12M | 87.66% |
| Dec 31, 2025 | 64.01M | -72.22% |
| Dec 31, 2024 | 230.43M | 143.12% |
| Dec 29, 2023 | 94.78M | 160.66% |
| Dec 30, 2022 | 36.36M | 267.00% |
| Dec 30, 2021 | 9.91M | -25.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 158.41M |
| HST Global | 131.71M |
| Nuo Therapeutics | 75.80M |
| Arch Biopartners | 62.37M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 43.94M |
| Oncotelic Therapeutics | 39.59M |
| LakeShore Biopharma | 34.82M |